Panaji: Verna-based Molbio Diagnostics has announced a $30 million investment in San Jose, US-based OptraSCAN. The Goan company said that the strategic partnership aims to develop advanced AI-powered diagnostic equipment for global healthcare providers.
The investment will accelerate OptraSCAN’s development of cutting-edge diagnostic testing equipment. “The strategic alliance with OptraSCAN is a significant step in our mission to make healthcare diagnostic devices accessible in India and beyond,” said Sriram Natarajan, chief executive officer of Molbio Diagnostics. He said that the use of technology will help enhance patient care and ensure access to timely and accurate diagnostics for patients.
The Molbio and OptraSCAN collaboration will leverage cloud-based systems for efficient slide scanning, image analysis, and secure data storage.
This approach promises faster, more accurate diagnoses and improved patient care, especially in rural and underserved areas.
Abhi Gholap, founder and CEO of OptraSCAN, said that the collaboration aims to bridge gaps in healthcare.
